We've found
						33,560
						 archived clinical trials in
						Neurology
					
				We've found
						33,560
						 archived clinical trials in
						Neurology
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
	
	Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
	
Updated: 11/30/2015
  
  
  	  A Prospective, Single-Arm, Clinical-Setting Study to Describe Efficacy, Tolerability and Convenience of Teriflunomide Treatment Using Patient Reported Outcomes (PROs) in Relapsing Multiple Sclerosis (RMS) Patients
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Development of a Motivational Intervention to Improve Treatment Adherence in MS
	
Updated: 11/30/2015
  
  
  Development of a Motivational Intervention to Improve Treatment Adherence in MS
		Status: Enrolling	
	Updated: 11/30/2015
	
	Development of a Motivational Intervention to Improve Treatment Adherence in MS
	
Updated: 11/30/2015
  
  
  	  Development of a Motivational Intervention to Improve Treatment Adherence in MS
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Development of a Motivational Intervention to Improve Treatment Adherence in MS
	
Updated: 11/30/2015
  
  
  Development of a Motivational Intervention to Improve Treatment Adherence in MS
		Status: Enrolling	
	Updated: 11/30/2015
	
	Development of a Motivational Intervention to Improve Treatment Adherence in MS
	
Updated: 11/30/2015
  
  
  	  Development of a Motivational Intervention to Improve Treatment Adherence in MS
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
	
Updated: 11/30/2015
  
  
  Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
		Status: Enrolling	
	Updated: 11/30/2015
	
	Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
	
Updated: 11/30/2015
  
  
  	  Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
	
Updated: 11/30/2015
  
  
  Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
		Status: Enrolling	
	Updated: 11/30/2015
	
	Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
	
Updated: 11/30/2015
  
  
  	  Development of a Talk Therapy Protocol to Help Patients Make Treatment Decisions in MS
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Advanced MRI Applications for Mild Traumatic Brain Injury
	
Updated: 11/30/2015
  
  
  Advanced MRI Applications for Mild Traumatic Brain Injury
		Status: Enrolling	
	Updated: 11/30/2015
	
	Advanced MRI Applications for Mild Traumatic Brain Injury
	
Updated: 11/30/2015
  
  
  	  Advanced MRI Applications for Mild Traumatic Brain Injury
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
	
Updated: 11/30/2015
  
  
  Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
		Status: Enrolling	
	Updated: 11/30/2015
	
	Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
	
Updated: 11/30/2015
  
  
  	  Advanced MRI Applications for Mild Traumatic Brain Injury - UCSF
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  	  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  	  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  	  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  	  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
	
	Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
	
Updated: 11/30/2015
  
  
  	  18F-AV-1451 Injection for Brain Imaging of Tau in Subjects With Progressive Supranuclear Palsy (PSP), Subjects With Corticobasal Degeneration (CBD) and Healthy Volunteers"
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	TBI MR Study 3 Houston Methodist
	
Updated: 11/30/2015
  
  
  Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3
		Status: Enrolling	
	Updated: 11/30/2015
	
	TBI MR Study 3 Houston Methodist
	
Updated: 11/30/2015
  
  
  	  Advanced MRI Applications for Mild Traumatic Brain Injury - Study 3
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
	
Updated: 11/30/2015
  
  
  Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
		Status: Enrolling	
	Updated: 11/30/2015
	
	An Intervention Trial for Cardiac Neuropathy in Type 1 Diabetes
	
Updated: 11/30/2015
  
  
  	  Oxidative Stress and Cardiovascular Denervation in Diabetes: An Interventional Trial
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
	
Updated: 11/30/2015
  
  
  Improving Affect and Behavior in Assisted Living Residents
		Status: Enrolling	
	Updated: 11/30/2015
	
	Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
	
Updated: 11/30/2015
  
  
  	  Improving Affect and Behavior in Assisted Living Residents
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
	
Updated: 11/30/2015
  
  
  Improving Affect and Behavior in Assisted Living Residents
		Status: Enrolling	
	Updated: 11/30/2015
	
	Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
	
Updated: 11/30/2015
  
  
  	  Improving Affect and Behavior in Assisted Living Residents
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Facilitating Caregiver Adaptation to Patient Institutionalization
	
Updated: 11/30/2015
  
  
  Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition
		Status: Enrolling	
	Updated: 11/30/2015
	
	Facilitating Caregiver Adaptation to Patient Institutionalization
	
Updated: 11/30/2015
  
  
  	  Intervention to Facilitate Family Caregiver Adaptation to Nursing Home Transition
		Status: Enrolling	
	Updated: 11/30/2015
Click here to add this to my saved trials
		    
		 
	  	
	Psychological Effects of Tai Chi Training
	
Updated: 12/1/2015
  
  
  Psychological Effects of Tai Chi Training
		Status: Enrolling	
	Updated: 12/1/2015
	
	Psychological Effects of Tai Chi Training
	
Updated: 12/1/2015
  
  
  	  Psychological Effects of Tai Chi Training
		Status: Enrolling	
	Updated: 12/1/2015
Click here to add this to my saved trials
		    
		 
	  	
	A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
	
Updated: 12/1/2015
  
  
  A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.
		Status: Enrolling	
	Updated: 12/1/2015
	
	A Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness
	
Updated: 12/1/2015
  
  
  	  A Double-Blind, Repeat-Dose, Parallel Group Study Comparing the Efficacy and Safety of Orally Administered Ibuprofen and Placebo in Delayed Onset Muscle Soreness.
		Status: Enrolling	
	Updated: 12/1/2015
Click here to add this to my saved trials
		    
		 
	  	
	ARC in Hemorrhagic Stroke
	
Updated: 12/1/2015
  
  
  Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit
		Status: Enrolling	
	Updated: 12/1/2015
	
	ARC in Hemorrhagic Stroke
	
Updated: 12/1/2015
  
  
  	  Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit
		Status: Enrolling	
	Updated: 12/1/2015
Click here to add this to my saved trials
		    
		 
	  	
	Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
	
Updated: 12/1/2015
  
  
  Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
		Status: Enrolling	
	Updated: 12/1/2015
	
	Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
	
Updated: 12/1/2015
  
  
  	  Project GET FIT With MS: Guidelines for Exercise Training and Fitness Outcomes in MS
		Status: Enrolling	
	Updated: 12/1/2015
Click here to add this to my saved trials
		    
		 
	  	
	Intra-arterial Magnesium Administration for Acute Stroke
	
Updated: 12/2/2015
  
  
  Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
		Status: Enrolling	
	Updated: 12/2/2015
	
	Intra-arterial Magnesium Administration for Acute Stroke
	
Updated: 12/2/2015
  
  
  	  Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
		Status: Enrolling	
	Updated: 12/2/2015
Click here to add this to my saved trials
		    
		 
	  	
	Intra-arterial Magnesium Administration for Acute Stroke
	
Updated: 12/2/2015
  
  
  Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
		Status: Enrolling	
	Updated: 12/2/2015
	
	Intra-arterial Magnesium Administration for Acute Stroke
	
Updated: 12/2/2015
  
  
  	  Intra-arterial Magnesium Therapy: A Novel Platorm for Neuroprotectant Delivery in Acute Stroke
		Status: Enrolling	
	Updated: 12/2/2015
Click here to add this to my saved trials
		    
		 
	  	
	A Study of Pregnenolone in the Treatment of Individuals With Autism
	
Updated: 12/2/2015
  
  
  An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
		Status: Enrolling	
	Updated: 12/2/2015
	
	A Study of Pregnenolone in the Treatment of Individuals With Autism
	
Updated: 12/2/2015
  
  
  	  An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism
		Status: Enrolling	
	Updated: 12/2/2015
Click here to add this to my saved trials
		    
		 
	  	
	An Open-Label Study of N-Acetyl Cysteine in Children With Autism
	
Updated: 12/2/2015
  
  
  An Open-Label Study of N-Acetyl Cysteine in Autism
		Status: Enrolling	
	Updated: 12/2/2015
	
	An Open-Label Study of N-Acetyl Cysteine in Children With Autism
	
Updated: 12/2/2015
  
  
  	  An Open-Label Study of N-Acetyl Cysteine in Autism
		Status: Enrolling	
	Updated: 12/2/2015
Click here to add this to my saved trials
		    
		 
	  	
	Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
	
Updated: 12/2/2015
  
  
  Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications
		Status: Enrolling	
	Updated: 12/2/2015
	
	Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
	
Updated: 12/2/2015
  
  
  	  Multiphase Study to Determine if Platelet Function Analysis Results Correlate With Ischemic Events and Bleeding Complications
		Status: Enrolling	
	Updated: 12/2/2015
Click here to add this to my saved trials
		    
		 
	  	
	Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
	
Updated: 12/3/2015
  
  
  Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
		Status: Enrolling	
	Updated: 12/3/2015
	
	Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
	
Updated: 12/3/2015
  
  
  	  Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms
		Status: Enrolling	
	Updated: 12/3/2015
Click here to add this to my saved trials
		    
		 
	  	
	In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
	
Updated: 12/3/2015
  
  
  In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
		Status: Enrolling	
	Updated: 12/3/2015
	
	In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
	
Updated: 12/3/2015
  
  
  	  In Vivo Corneal Confocal Microscopy for Non-invasive Assessment of Diabetic Peripheral Neuropathy
		Status: Enrolling	
	Updated: 12/3/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
	
Updated: 12/3/2015
  
  
  Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
		Status: Enrolling	
	Updated: 12/3/2015
	
	Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
	
Updated: 12/3/2015
  
  
  	  Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
		Status: Enrolling	
	Updated: 12/3/2015
Click here to add this to my saved trials
		    
		 
	  	
	Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
	
Updated: 12/3/2015
  
  
  Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
		Status: Enrolling	
	Updated: 12/3/2015
	
	Using Transcranial Direct Current Stimulation (tDCS) to Improve Post-Stroke Aphasia
	
Updated: 12/3/2015
  
  
  	  Can Enhancing Left Lateralization Using Transcranial Direct Current Stimulation Improve Recovery From Post-Stroke Aphasia?
		Status: Enrolling	
	Updated: 12/3/2015
Click here to add this to my saved trials
		    
		 
	  	
	Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
	
Updated: 12/3/2015
  
  
  Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
		Status: Enrolling	
	Updated: 12/3/2015
	
	Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
	
Updated: 12/3/2015
  
  
  	  Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
		Status: Enrolling	
	Updated: 12/3/2015
Click here to add this to my saved trials
		    
		 
	  	
	Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
	
Updated: 12/3/2015
  
  
  Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
		Status: Enrolling	
	Updated: 12/3/2015
	
	Examining the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Measuring Symptom Change
	
Updated: 12/3/2015
  
  
  	  Validity and Reliability of the Spasmodic Dysphonia Diagnosis and Assessment Procedure (SD-DAP) for Quantifying Symptom Change
		Status: Enrolling	
	Updated: 12/3/2015
Click here to add this to my saved trials
		    
		 
	  	
	Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
	
Updated: 12/4/2015
  
  
  Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis
		Status: Enrolling	
	Updated: 12/4/2015
	
	Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
	
Updated: 12/4/2015
  
  
  	  Phase II, Randomized, Placebo Controlled Trial of the Safety and Tolerability of Mycophenolate in Children With Juvenile Neuronal Ceroid Lipofuscinosis
		Status: Enrolling	
	Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
	
		Status: Enrolling	
	
Updated: 12/4/2015
  
  
  Updated: 12/4/2015
	
	Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
	
		Status: Enrolling	
	
Updated: 12/4/2015
  
  
  	  Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
	
Updated: 12/4/2015
  
  
  Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke
		Status: Enrolling	
	Updated: 12/4/2015
	
	Repetitive Transcranial Magnetic Stimulation Use in Acute Stroke
	
Updated: 12/4/2015
  
  
  	  Real vs Sham rTMS Combined With Conventional Therapy in Acute Stroke
		Status: Enrolling	
	Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
	
Updated: 12/4/2015
  
  
  A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
		Status: Enrolling	
	Updated: 12/4/2015
	
	A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
	
Updated: 12/4/2015
  
  
  	  A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
		Status: Enrolling	
	Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
	
Updated: 12/4/2015
  
  
  A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
		Status: Enrolling	
	Updated: 12/4/2015
	
	A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
	
Updated: 12/4/2015
  
  
  	  A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
		Status: Enrolling	
	Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
	
Updated: 12/4/2015
  
  
  A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
		Status: Enrolling	
	Updated: 12/4/2015
	
	A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
	
Updated: 12/4/2015
  
  
  	  A Clinical Study of Patients With Symptomatic Neurogenic Orthostatic Hypotension to Assess Sustained Effects of Droxidopa Therapy
		Status: Enrolling	
	Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
	
		Status: Enrolling	
	
Updated: 12/4/2015
  
  
  Updated: 12/4/2015
	
	Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
	
		Status: Enrolling	
	
Updated: 12/4/2015
  
  
  	  Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
	
		Status: Enrolling	
	
Updated: 12/4/2015
  
  
  Updated: 12/4/2015
	
	Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia
	
		Status: Enrolling	
	
Updated: 12/4/2015
  Updated: 12/4/2015
Click here to add this to my saved trials
		    
		 
	  	
	Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
	
Updated: 12/7/2015
  
  
  A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
		Status: Enrolling	
	Updated: 12/7/2015
	
	Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
	
Updated: 12/7/2015
  
  
  	  A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
		Status: Enrolling	
	Updated: 12/7/2015
Click here to add this to my saved trials
		    
		 
	  	
	Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
	
Updated: 12/7/2015
  
  
  A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
		Status: Enrolling	
	Updated: 12/7/2015
	
	Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
	
Updated: 12/7/2015
  
  
  	  A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
		Status: Enrolling	
	Updated: 12/7/2015
Click here to add this to my saved trials
		    
		 
	  	
	Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
	
Updated: 12/7/2015
  
  
  A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
		Status: Enrolling	
	Updated: 12/7/2015
	
	Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2
	
Updated: 12/7/2015
  
  
  	  A Phase 2 Safety Study in Which Ischemic Stroke Patients Will be Randomized Within 24 Hours of Symptom Onset to Placebo or Oral Lovastatin 640 mg Per Day for 3 Days.
		Status: Enrolling	
	Updated: 12/7/2015
Click here to add this to my saved trials
		    
		 
	  